TEVAGRASTIM 48 MUI/0.8 ml, solution for injection or infusion 5 syringes of 0.8 ml
Active ingredients: Filgrastim
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection or infusion5 syringes of 0.8 mlintraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TEVAGRASTIM 48 MUI/0,8 ml, solution injectable ou pour perfusion
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 5 seringue(s) préremplie(s) en verre de 0,8 ml avec aiguille(s) avec dispositif de sécurité
- Marketing authorisation holder
- TEVA (ALLEMAGNE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 May 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65313021CIP73864971CIP133400938649710Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FILGRASTIMsolution | 480 microgrammes · une seringue préremplie de 0,8 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.